doi:10.1093/ejcts/ezt320 Advance Access publication 17 July 2013 Lessons learned with tricuspid valve replacement

van Slooten et al. [1] have demonstrated prosthetic valve-related complications to be more common in patients with congenital heart disease and to be unrelated to prosthesis material at late follow-up. In addition, their data suggested that patient–prosthesis mismatch may have had a negative effect on event-free survival. While repair of the tricuspid valve is preferred in almost all cir-cumstances, there are situations when repair may not be feasible, particularly in the congenital population because of significant anatomical tricuspid abnormalities, or because tricuspid repair(s) has already been performed in the past. Numerous tricuspid valvuloplasty techniques have been described in the congenital literature, largely because of the wide variety of abnormalities seen with Ebstein malformation (EM) [2, 3] and other congenital tricuspid anomalies [4]. These various repair techniques can be applied in a ‘re-repair o